Manciu et al. in 2016 used Raman spectroscopy (532 nm excitation source) to evaluate the biological activity of epidermal growth factor receptors on the surface of breast cancer cells with the goal of diagnosing breast cancer using specific receptor activity. This evidence concerns the gene EGFR and breast carcinoma.